Press release
Jan 23, 2012

Sosei Announces Collaboration with CEOLIA Pharma

Tokyo, Japan – 23 January 2012: Sosei Group Corporation (“Sosei”; TSE Mothers Index: 4565), announced today that its wholly owned subsidiary Activus Pharma (“Activus”) has entered into a Technical Alliance Agreement with CEOLIA Pharma Co., Ltd. (“CEOLIA”).

Under the terms of the agreement, CEOLIA and Activus will jointly conduct research and development to assess the feasibility of development of a novel oral formulation using Activus Pure Nano-particle Technology (“APNT”).